Sangamo Therapeutics
SGMO
#10598
Rank
ยฃ23.12 M
Marketcap
ยฃ0.05582
Share price
0.00%
Change (1 day)
-85.32%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -ยฃ82.12 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ34.55 Million. In 2025 the company made an earning of -ยฃ81.47 Million a decrease over its 2024 earnings that were of -ยฃ74.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ82.12 Million0.79%
2025 -ยฃ81.47 Million9.71%
2024 -ยฃ74.26 Million-17.27%
2023 -ยฃ89.76 Million-40.88%
2022 -ยฃ0.16 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ97.72 Million23.17%
2019 -ยฃ79.34 Million36.33%
2018 -ยฃ58.2 Million36.89%
2017 -ยฃ42.52 Million-22.32%
2016 -ยฃ54.73 Million54.86%
2015 -ยฃ35.35 Million75.62%
2014 -ยฃ20.13 Million0.13%
2013 -ยฃ20.1 Million
2011 -ยฃ27.02 Million43.66%
2010 -ยฃ18.81 Million28.52%
2009 -ยฃ14.64 Million-23.55%
2008 -ยฃ19.15 Million2.45%
2007 -ยฃ18.69 Million19.5%
2006 -ยฃ15.64 Million50.78%
2005 -ยฃ10.37 Million75%
2004 -ยฃ5.93 Million-33.25%
2003 -ยฃ8.88 Million-62.27%
2002 -ยฃ23.53 Million102.82%
2001 -ยฃ11.61 Million23.21%
2000 -ยฃ9.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.12 B-17,069.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ8.33 B-10,117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ0.33 B-503.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ0.33 Billion 285.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ1.92 Billion 2,196.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.07 B-6,193.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.92 B-1,207.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ32.93 M-139.58%๐Ÿ‡บ๐Ÿ‡ธ USA